Opposition MLAs want more information about Nova Scotia s back-to-school plan cbc.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cbc.ca Daily Mail and Mail on Sunday newspapers.
Nearly two years into the pandemic, Dr. Joanne Langley says Nova Scotians have learned a lot about how COVID-19 spreads and how to keep themselves safe.
Forty-three per cent of eligible Nova Scotians have received a third dose. In New Brunswick, 38.7 per cent have their booster.On Prince Edward Island that figure is 28 per cent.
An important clinical trial looking at details of safety and immune-stimulating effects of mixed doses was undermined by changing vaccine protocols and bureaucratic complexity.
One dose of Ad5-nCoV (Convidecia), a COVID-19 vaccine developed in China, is 57.5% effective against symptomatic COVID-19 and 91.7% effective against severe COVID-19 disease beginning 28 days postvaccination, according to a phase 3 randomized controlled trial published in The Lancet.